Healthcare -
Biotechnology - NASDAQ - US
$ 2.4
-7.69 %
$ 115 M
Market Cap
-1.74
P/E
SAVA - GROSS PROFIT
Gross Profit SAVA - Cassava Sciences, Inc.
-89.4 M
LAST VALUE
-1194.06%
2 YEAR CAGR
-319.30%
5 YEAR CAGR
-12.25%
10 YEAR CAGR